The management of endometrial hyperplasia: an evaluation of current practice.
about
Absolute risk of endometrial carcinoma during 20-year follow-up among women with endometrial hyperplasia.The effectiveness of levonorgestrel releasing intrauterine system in the treatment of endometrial hyperplasia in Korean women.Comparison of WHO and endometrial intraepithelial neoplasia classifications in predicting the presence of coexistent malignancy in endometrial hyperplasia.Role of progesterone in endometrial cancerLevonorgestrel-impregnated intrauterine device as treatment for endometrial hyperplasia: a national multicentre randomised trial.Complex hyperplasia with and without atypia: clinical outcomes and implications of progestin therapyInfluence of AKT on progesterone action in endometrial diseases.Biomarkers of progestin therapy resistance and endometrial hyperplasia progression.Coexisting carcinoma in endometrial hyperplasia: does more risk factor mean better discrimination?Endometrial carcinoma risk among women diagnosed with endometrial hyperplasia: the 34-year experience in a large health plan.Risk of subsequent endometrial carcinoma associated with endometrial intraepithelial neoplasia classification of endometrial biopsies.Clinical applications of levonorgestrel-releasing intrauterine system to gynecologic diseases.The levonorgestrel-releasing intrauterine system: Safety, efficacy, and patient acceptability.Ultrasonographic endometrial thickness measurement is predictive for treatment response in simple endometrial hyperplasia without atypiaEndometrial cancer, types, prognosis, female hormones and antihormones.Risk for advanced-stage endometrial cancer in surgical specimens from patients with complex endometrial hyperplasia with atypia.Endometrial cancer: multiplexed Luminex approaches for early detection.Levonorgestrel-releasing intrauterine device versus dydrogesterone for management of endometrial hyperplasia without atypia.Impact of body mass index and operative approach on surgical morbidity and costs in women with endometrial carcinoma and hyperplasia.Perimenopausal bleeding: Patterns, pathology, response to progestins and clinical outcome.HE4 is a novel tissue marker for therapy response and progestin resistance in medium- and low-risk endometrial hyperplasia.LNG-IUS versus oral progestogen treatment for endometrial hyperplasia: a long-term comparative cohort study.Cyclic versus continuous medroxyprogesterone acetate for treatment of endometrial hyperplasia without atypia: a 2-year observational study.Depo-Provera Versus Norethisterone Acetate in Management of Endometrial Hyperplasia Without Atypia.Comparison of diagnostic accuracy between endometrial curettage and pipelle aspiration biopsy in patients treated with progestin for endometrial hyperplasia: a Korean Gynecologic Oncology Group Study (KGOG 2019).Clinical outcome in diagnostically ambiguous foci of 'gland crowding' in the endometrium.
P2860
Q33710581-7995A9AB-0A1F-4D6A-9564-C2F789CC2212Q33955664-A3A138A8-2DA3-4C42-BC55-FE2336694D15Q33955748-9D690773-5BBF-4A13-AF2D-8AFE7C00402BQ34095034-A4473AA6-47B0-4E17-87FC-7F8FFE036355Q34140046-5BD430ED-C505-49A4-93F2-34A25B500BE3Q34173018-9CA1D5CE-C0C5-4A74-BB0A-CEE945C73730Q35617565-96B4E404-549F-4A75-84C7-30076B2A8258Q36099979-F2BCD198-61FE-454B-BFB0-2A4C758BF615Q36547004-64D62F5D-2FAF-4749-BA29-E4F9C10C0022Q36608842-6E6EC84C-2759-4150-B9CD-713705152285Q36983146-26C1D079-81AA-483D-A02B-179DA57A5328Q37199883-EB1C4DC2-7C84-406C-8970-816FCA46F38EQ37298238-83DCC1E8-D56F-4E57-868E-F940E0C9A81CQ37437341-766B17F0-5E3A-4E52-96C0-1DA1EDB95831Q37855938-567CA8C5-9D32-4055-AFCA-917C4F156A35Q37953177-AFA03020-3D19-4F0D-B4F2-E8D19AAFA8B6Q38089759-90B46EDC-4566-436C-98B2-83AFF4EBB45DQ38984243-2F097D67-8FD9-430F-BB16-DF68A67B58CCQ38993841-F7F8A304-CB13-4AA5-B3DD-D2777D70B350Q39395322-99A259E2-B4F4-40B1-BF76-059BDB262EFFQ41095997-DF33386C-702A-4E24-B94F-EE9891A3CD6AQ45168639-9730B866-0053-4075-96DA-0C709F9D8FA9Q46155965-1FFC7DD4-818B-456A-883F-EEF6B7B9587EQ46974182-3F5298B5-FEC7-4B6B-9D7E-E7BDF258F424Q51835901-7F2308D6-D0C6-40EC-9823-DFD933AA390DQ53308994-E0425192-D897-4C9D-8525-A9D6D6FA27AB
P2860
The management of endometrial hyperplasia: an evaluation of current practice.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
The management of endometrial hyperplasia: an evaluation of current practice.
@ast
The management of endometrial hyperplasia: an evaluation of current practice.
@en
type
label
The management of endometrial hyperplasia: an evaluation of current practice.
@ast
The management of endometrial hyperplasia: an evaluation of current practice.
@en
prefLabel
The management of endometrial hyperplasia: an evaluation of current practice.
@ast
The management of endometrial hyperplasia: an evaluation of current practice.
@en
P2093
P1476
The management of endometrial hyperplasia: an evaluation of current practice.
@en
P2093
Deepa Neelakantan
Janesh K Gupta
T Justin Clark
P304
P356
10.1016/J.EJOGRB.2005.09.004
P577
2005-10-24T00:00:00Z